546
Views
39
CrossRef citations to date
0
Altmetric
Review Article

Phoma Saccardo: Distribution, secondary metabolite production and biotechnological applications

, , , , &
Pages 182-196 | Received 26 Jul 2008, Accepted 17 Apr 2009, Published online: 22 Jul 2009
 

Abstract

Phoma Sacc. is an ubiquitous fungus, which has been reported from plants, soil, human beings, animals, and air. Some species of Phoma like P. sorghina, P. herbarum, P. exigua var. exigua, P. macrostoma, P. glomerata, Phoma macdonaldii, Phoma tracheiphila, Phoma proboscis, P. multirostrata, and Phoma foveata secrete phytotoxin and anthraquinone pigments as secondary metabolites, which have great potential for the biological control of weeds, and can be exploited for the production of mycopesticides, agrophytochemicals, and dyes. Some other species produce pharmaceutically active metabolites, viz., Sirodesmins, Phomenoic acid, Phomenolactone, Phomadecalins, Phomactin A, Phomasetin, Squalestatin-1 (S1), and Squalestatin-2 (S2). The secondary metabolites secreted by some species of Phoma are antitumor, antimicrobial, and anti-HIV. Equisetin and Phomasetin obtained from species of Phoma are useful against AIDS. The main goal of the present review is to discuss secondary metabolite production by species of Phoma and their utilization as antibiotics and as biocontrol agents.

Acknowledgments

The authors would like to thank Dr Sheo Singh, Merck Research Laboratories, New Jersey; Dr. M. S. C. Pedras, Canada Research Chair in Bioorganic and Agricultural Chemistry, University of Saskatchewan, SASKATOON, Canada; Dr. Barbara Schulz, Institut fuer Mikrobiologie Technische Universitaet Braunschweig, Germany; Dr. Masatoshi Taniguchi, Astellas Pharma Inc., Japan; Dr. Monica Tallarico, Pupo, Brazil, Prof. Dr. h.c. K. Krohn, Department Chemie, Universität Paderborn, Warburger Str., Germany, for suggestions and supply of literature.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.